Apraglutide

CAT:
804-HY-P1714-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Apraglutide - image 1

Apraglutide

  • Description:

    Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum[1].
  • Product Name Alternative:

    FE 203799
  • UNSPSC:

    12352209
  • Target:

    GLP Receptor
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Apraglutide.html
  • Purity:

    99.33
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C ([C@@H] (N) CC1=CNC=N1) NCC (N[C@H] (C (NCC (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N) =O) CC (O) =O) =O) [C@@H] (C) O) =O) [C@H] (CC) C) =O) CCCCN) =O) [C@@H] (C) O) =O) CCC (N) =O) =O) [C@H] (CC) C) =O) CC (C) C) =O) CC2=CNC3=CC=CC=C23) =O) CC (N) =O) =O) [C@H] (CC) C) =O) CC4=CC=CC=C4) =O) CC (O) =O) =O) CCCNC (N) =N) =O) C) =O) C
  • Molecular Formula:

    C172H263N43O52
  • Molecular Weight:

    3765.25
  • References & Citations:

    [1]Slim GM, et al. Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum. JPEN J Parenter Enteral Nutr. 2019 Jan 6.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Scientific Category:

    Peptides
  • Clinical Information:

    Phase 3
  • CAS Number:

    1295353-98-8